
CAS 2079895-42-2
:Formule :C23H18N6O2S
InChI :InChI=1S/C23H18N6O2S/c24-32(30,31)19-11-9-18(10-12-19)27-23-28-20(21-22(29-23)26-14-25-21)17-8-4-7-16(13-17)15-5-2-1-3-6-15/h1-14H,(H2,24,30,31)(H2,25,26,27,28,29)
Code InChI :FUGRWXRQJGJIER-UHFFFAOYSA-N
SMILES :C1=CC=C(C=C1)C2=CC(=CC=C2)C3=C4C(=NC(=N3)NC5=CC=C(C=C5)S(=O)(=O)N)N=CN4
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
CDK2-IN-4
CAS :CDK2-IN-4 is a potent and selective inhibitor of CDK2 with an IC50 of 44 nM for CDK2/cyclin A.Formule :C23H18N6O2SDegré de pureté :97.24% - 99.10%Couleur et forme :SolidMasse moléculaire :442.49Ref: TM-T14916
1mg82,00€5mg192,00€1mL*10mM (DMSO)212,00€10mg304,00€25mg522,00€50mg713,00€100mg1.018,00€CDK2-IN-4
CAS :4-((6-([1,1'-Biphenyl]-3-yl)-7H-purin-2-yl)amino)benzenesulfonamideFormule :C23H18N6O2SDegré de pureté :98%Masse moléculaire :442.49CDK2-IN-4
CAS :CDK2-IN-4 is a synthetic small molecule that inhibits the activity of kinases. It has been shown to inhibit the activity of CDK2, CDK4, and CDK6 in leukaemia cells. CDK2-IN-4 also inhibits the activity of kinases in other cancer cell lines. The synthesis of this compound was accomplished using a cross-coupling reaction between aryl boronic acid and aniline derivatives. This synthesis was pursued through kinetic studies involving alkylation reactions with 2-(3,5-dimethylpyrazol-1-yl)pyridinium bromide (DMPP). Kinetic parameters were determined by isothermal titration calorimetry (ITC).Formule :C23H18N6O2SDegré de pureté :Min. 95%Masse moléculaire :442.49 g/mol





